ITI Balanced Advantage Fund - Growth - Regular Plan

Other Plans and Options
  • 0.04 %Nav, as on 04-06-2020

  • Previous Nav

  • Net Change on 04-06-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to seek capital appreciation by investing in equity and equity related securities and fixed income instruments. The allocation between equity instruments and fixed income will be managed dynamically so as to provide investors with long term capital appreciation. However, there can be no assurance that the investment objective of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
CRISIL Hybrid 50+50 - Moderate Index N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
HDFC Balance Advantage Fund - Growth Option Sep 11, 2000 -19.80 -0.32 5.15 1.73 33,772.47

Fund Holdings as on 31-May-2020

  • TREPS 01-June-2020

  • HDFC Bank Limited

  • Net Receivables / (Payables)

  • State Bank of India

  • NTPC Limited

  • 4.75% HDFC Bank Limited (24/06/2020)

  • Infosys Limited

  • ITC Limited

  • 6.25% State Bank of India (29/12/2020)

  • Alembic Pharmaceuticals Limited

  • TVS Motor Company Limited

  • Maruti Suzuki India Limited

  • Torrent Power Limited

  • ICICI Securities Limited

  • PI Industries Limited

  • Lupin Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Pidilite Industries Limited

  • Avenue Supermarts Limited

  • Marico Limited

  • UltraTech Cement Limited

  • Ambuja Cements Limited

  • ACC Limited

  • Sanofi India Limited

  • Exide Industries Limited

  • Hindustan Petroleum Corporation Limited

  • Endurance Technologies Limited

  • Oracle Financial Services Software Limited

  • Nippon Life India Asset Management Limited

  • Escorts Limited

  • Tata Elxsi Limited

View More

  • Miscellaneous

  • Bank - Private

  • Pharmaceuticals & Drugs

  • Power Generation/Distribution

  • IT - Software

  • Bank - Public

  • Cement & Construction Materials

  • Cigarettes/Tobacco

  • Automobile Two & Three Wheelers

  • Automobiles - Passenger Cars

  • Finance - Stock Broking

  • Pesticides & Agrochemicals

  • Chemicals

  • Retailing

  • Consumer Food

  • Batteries

  • Refineries

  • Auto Ancillary

  • Finance - Asset Management

  • Automobiles-Tractors

View More

Fund Manager

  • Cash

  • Deposits

  • Equity

View More

About ITI Balanced Advantage Fund

Scheme Analysis

ITI Balanced Advantage Fund is a Hybrid - Balanced Advantage fund and belongs to ITI Mutual Fund. It was launched on 31-Dec-2019 and currently has an AUM of ₹204.40 crore. ITI Balanced Advantage Fund is benchmarked against CRISIL Hybrid 50+50 - Moderate Index as primary index.

The NAV of ITI Balanced Advantage Fund ended up ₹0(0.04%)yesterday to ₹8.5828.

Among its top 3 holdings the fund has exposure to TREPS 01-June-2020, and

The ITI Balanced Advantage Fund is managed by Pradeep Gokhale and George Heber Joseph.

Fund House Contact

Naman Midtown, A - Wing, 21st Floor, Senapati Bapat Marg, Elphinstone Road Mumbai - 400 013

022-66214999
mfassist@itiorg.com